Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters
AssigneesGreenpharma, Bioalternatives SAS
InventorsPhilippe Bernard, Francois-Xavier Bernard
Life of this patent
Estimating the term…
Abstract
Describe is a method of administering to a subject silymarin, or of the main constituents thereof alone or as a mixture, chosen from silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3, 5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isosilybin, silydianin, silychristin, silandrin, silymonin and taxifolin, isolated enantiomers thereof and also salts thereof.
Claims8
A method of inducing or stimulating pigmentation of skin in a subject in need of such inducing or stimulating, the method comprising administering to the subject silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isolated enantiomers thereof and/or salts thereof to induce or stimulate the pigmentation of skin in the subject.
A method of restoring pigmentation of skin in a subject suffering from hypopigmentation, the method comprising administering to the subject silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isolated enantiomers thereof and/or salts thereof to restore the pigmentation of skin in the subject.
Dependencies are inferred from the claim text.